These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19819688)

  • 41. [Incidence of infected surgical wound and prophylaxis with cefotaxime in cesarean section].
    Lemus Rocha R; García Gutiérrez LB; Basavilvazo Rodríguez MA; Cruz Avelar A; Peralta Pedrero ML; Hernández Valencia M
    Ginecol Obstet Mex; 2005 Oct; 73(10):537-43. PubMed ID: 16583834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
    Di Carlo I; Barbagallo F; Toro A; Sofia M; Lombardo R; Cordio S
    Ann Surg Oncol; 2005 Jul; 12(7):570-3. PubMed ID: 15889215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative infections and antibiotic prophylaxis for hysterectomy in Sweden: a study by the Swedish National Register for Gynecologic Surgery.
    Löfgren M; Poromaa IS; Stjerndahl JH; Renström B
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1202-7. PubMed ID: 15548157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial.
    Gossner L; Keymling J; Hahn EG; Ell C
    Endoscopy; 1999 Feb; 31(2):119-24. PubMed ID: 10223359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices.
    Burgher AH; Barnett CF; Obray JB; Mauck WD
    Pain Pract; 2007 Sep; 7(3):279-84. PubMed ID: 17714108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infective complications according to duration of antibiotic treatment in acute abdomen.
    Gleisner AL; Argenta R; Pimentel M; Simon TK; Jungblut CF; Petteffi L; de Souza RM; Sauerssig M; Kruel CD; Machado AR
    Int J Infect Dis; 2004 May; 8(3):155-62. PubMed ID: 15109590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Strategies in antibiotic prophylaxis in abdominal hysterectomy].
    Tsankova M; Raĭcheva R
    Akush Ginekol (Sofiia); 1998; 37(1):25-7. PubMed ID: 9770793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implementing 1-dose antibiotic prophylaxis for prevention of surgical site infection.
    Fonseca SN; Kunzle SR; Junqueira MJ; Nascimento RT; de Andrade JI; Levin AS
    Arch Surg; 2006 Nov; 141(11):1109-13; discussion 1114. PubMed ID: 17116804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications.
    Di Carlo I; Cordio S; La Greca G; Privitera G; Russello D; Puleo S; Latteri F
    Arch Surg; 2001 Sep; 136(9):1050-3. PubMed ID: 11529829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolongation of antibiotic prophylaxis after clean and clean-contaminated surgery and surgical site infection.
    De Chiara S; Chiumello D; Nicolini R; Vigorelli M; Cesana B; Bottino N; Giurati G; Caspani ML; Gattinoni L
    Minerva Anestesiol; 2010 Jun; 76(6):413-9. PubMed ID: 20473254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection.
    Penel N; Yazdanpanah Y; Chauvet MP; Clisant S; Giard S; Neu JC; Lefebvre D; Fournier C; Bonneterre J
    J Surg Oncol; 2007 Aug; 96(2):124-9. PubMed ID: 17443747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Implantable devices for permanent venous access. A single-center prospective study comparing an AIDS population with a control population (80 cases)].
    Johanet H; Saliou C; Marmuse JP; Benhamou G; Charleux H
    Ann Chir; 1991; 45(6):497-501. PubMed ID: 1929166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective randomized and placebo-controlled study for the evaluation of antibiotic prophylaxis in transurethral resection of the prostate.
    Ozturk M; Koca O; Kaya C; Karaman MI
    Urol Int; 2007; 79(1):37-40. PubMed ID: 17627166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The role of drainage and antibiotic prophylaxis in thyroid surgery].
    De Salvo L; Razzetta F; Tassone U; Arezzo A; Mattioli FP
    Minerva Chir; 1998 Nov; 53(11):895-8. PubMed ID: 9973793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients.
    Johnson E; Babb J; Sridhar D
    J Vasc Interv Radiol; 2016 Mar; 27(3):339-43; quiz 344. PubMed ID: 26776446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantable venous access devices: an alternative method of extended cancer care.
    Welling RE; Hall JM; Meyer RL; Arbaugh JJ
    J Surg Oncol; 1986 Oct; 33(2):73-5. PubMed ID: 3762187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensory perceptions of patients with cancer undergoing surgical insertion of a totally implantable venous access device: a qualitative, exploratory study.
    Goossens E; Goossens GA; Stas M; Janssens C; Jérôme M; Moons P
    Oncol Nurs Forum; 2011 Jan; 38(1):E20-6. PubMed ID: 21186148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.